Biochemistry, Genetics and Molecular Biology
Cancer Cell
100%
Array Comparative Genomic Hybridization
87%
MicroRNA
74%
B Cell
63%
Tumor Suppressor Gene
52%
Chromosome 3
43%
Gene Expression
41%
Exome Sequencing
35%
Tumor Suppressor Protein
35%
Cytogenetics
33%
Messenger RNA
33%
Genetics
31%
Comparative Genomic Hybridization
30%
Somatic Mutation
29%
Epigenetics
28%
Copy-Number Variation
27%
Yeast Artificial Chromosome
27%
Fusion Gene
27%
RNA
26%
Chromosome 6
25%
Epidermal Growth Factor Receptor
25%
Next Generation Sequencing
24%
Microsatellite DNA
23%
Microarrays
23%
Tyrosine Kinase Inhibitor
21%
Fluorescence in Situ Hybridization
21%
RNA Sequence
20%
Amplicon
20%
Long Noncoding RNA
19%
Carcinogenesis
19%
Long Non-Coding RNA
19%
Single-Nucleotide Polymorphism
18%
Loss of Heterozygosity
18%
Crizotinib
18%
SETD2
18%
Homogeneously Staining Region
18%
Anaplastic Lymphoma Kinase
18%
Myc
18%
Mesenchymal-Epithelial Transition
18%
Chromosome Regions
18%
Ubiquitin-Conjugating Enzyme
18%
Allele
18%
Mutated Genes
17%
Karyotype
17%
Polymerase Chain Reaction
17%
Chromosomal Aberration
17%
Heterozygosity
15%
Monospecific Antibody
15%
PBRM1
15%
Haploinsufficiency
15%
Medicine and Dentistry
Neoplasm
83%
Lung Cancer
65%
Clear Cell Renal Cell Carcinoma
44%
Small Cell Lung Cancer
38%
microRNA
33%
Malignant Neoplasm
29%
Biological Marker
26%
Cell Line
25%
B Cell
21%
Colorectal Liver Metastasis
18%
Cancer Cell
18%
Tyrosine-Kinase Inhibitor
18%
Cell-Free DNA
18%
Carcinogenesis
16%
Arm
16%
Epidermal Growth Factor Receptor
16%
Non Small Cell Lung Cancer
16%
Comparative Genomic Hybridization
13%
Tumor Progression
12%
Polymerase Chain Reaction
12%
Tumor Suppressor Gene
12%
Glycoprotein
11%
Clear Cell
11%
Formaldehyde
11%
RNA Sequence
11%
Lymph Node Metastasis
11%
Chromosome 3
11%
Metastatic Carcinoma
10%
Lung Cancer Cell Line
10%
Resistance Mutation
10%
Ovarian Cancer
10%
Diffuse Large B-Cell Lymphoma
10%
Salivary Gland
10%
Polymerase Chain Reaction
10%
Oncogene
9%
Hereditary Nonpolyposis Colorectal Cancer
9%
Cancer Risk
9%
Systematic Review
9%
Titrimetry
9%
Burkitt's Lymphoma
9%
Crizotinib
9%
Immunoprecipitation
9%
Wolf-Hirschhorn Syndrome
9%
DNA Sequence
9%
Lung Tumor
9%
Histone Methyltransferase
9%
Epithelial Cell
9%
Semaphorin 3A
9%
Semaphorin
9%
Calcium-Binding Protein
9%
Keyphrases
Tumor
27%
Copy number Gain
20%
Loss of Heterozygosity
18%
Breakpoint Regions
18%
After Surgery
18%
Yeast Artificial Chromosome
18%
Colorectal Liver Metastases
18%
H3K36me3
13%
Targetome
12%
UBE1L
11%
Metagenomic Next-generation Sequencing (mNGS)
10%
MiR-17
9%
B Cells
9%
Copy number Variation
9%
PMS2
9%
Past-present
9%
Lynch Syndrome
9%
Futures Past
9%
Mutational Evolution
9%
Dmin
9%
N-Myc
9%
Resistant Mechanism
9%
Wolf-Hirschhorn Syndrome
9%
Hodgkin Lymphoma
9%
Breakage Characterisation
9%
18p Deletion Syndrome
9%
Tumor Phenotype
9%
Clinical Value
9%
Myoepithelioma
9%
Post-transplant Lymphoproliferative Disorder
9%
Practical Guidelines
9%
Burkitt Lymphoma
9%
Cell-free DNA (cfDNA)
9%
Loss Analysis
9%
Microsatellite Repeats
9%
Non-small Cell Lung Cancer (NSCLC)
9%
CNTN4
9%
MiR-301a-3p
9%
Normal B Cells
9%
Segmental Duplication
9%
Chromosomal Instability
9%
MiR-335-5p
9%
RBM6
9%
Transcriptome Changes
9%
3p21.3
9%
Flanking Genes
9%
KPNA2
9%
RBM5
9%
Global Correlation
9%
3q Duplication Syndrome
9%
